Our commitment to the health of people and the planet
We prioritise sustainability that is put into action, consistent with our mission “Make health a positive practice, accessible to everyone, kind to the planet”, emphasising the centrality of our role as a partner of the pharmaceutical industry in developing increasingly widespread, effective and sustainable medical practices.
“We have taken significant steps towards sustainability, defining a strategic plan based on four areas of action.”
Our sustainability plan identifies four types of responsibilities to be pursued: production, organizational, environmental and social.
We are at the forefront of creating sustainable pharmaceutical packaging. For more than 15 years, we have been researching innovative solutions that respect the planet while preserving the effectiveness of medicines and improving people's health.
We seek to minimize the environmental impact of what we do by striving to optimize every aspect of our industrial processes: from using more sustainable raw materials to reducing water and energy consumption by pursuing strategies to integrate renewable sources.
We support the well-being of people and communities. We take concrete action to make the most out of our talent, to protect the health and safety of those who work with us through the continuous improvement of training and prevention programs, and we support local associations and educational organizations.
We have adopted a sound and transparent governance model, which is subject to continuous review and updating according to the latest national and international legislation. Sound decision-making processes and appropriate controls are a priority of our Group.
EcoPositive, our sustainable products
EcoPositive is our range of eco-friendly solutions that includes a vast assortment of products made from sustainable glass and plastic.
Our EcoPositive line is the result of research that began over 15 years ago, and that continues to evolve based on three different approaches.
Innovation for sustainability
Our open and participatory innovation program researches sustainable materials, processes and business models.
Our responsible approach translates into firm action. Therefore, we have set medium- to long-term goals to generate positive impact in our four areas of responsibility. First of all, to use 50% sustainable raw materials for our production by 2025.
sustainable raw materials for our production by 2025
reduction in water consumption by 2030
reduction in CO2 emissions by 2030
of our suppliers evaluated by EcoVadis by 2026
gender pay gap by 2028
Bormioli Pharma reaffirms its commitment to environmental and social sustainability with the presentation of the 2nd edition of its ESG Report
One of the main objectives is to cut CO2 emissions by 30% by 2030, while the target for the reduction of water consumption has been redefined (from -30% to -41%) in light of the significant improvements already achieved in 2022.
Bormioli Pharma and IQVIA Italy together to identify patients’ real needs
Patients' usage habits regarding injectables and topicals were investigated by means of one-to-one interviews and focus groups. The investigation brought to light critical issues and potential areas for development.
Bormioli Pharma presents at Pharmapack Europe the evolution of its pharma packaging offer, focused on sustainability and new IoT technologies
The company will display its wide product range in Paris on 1st-2nd February (Porte de Versailles Expo, booth A68-A70). Bormioli Pharma will also showcase new prototypes, among which a connected medical device able to administer ophthalmic drugs through nebulization.
Bormioli Pharma and Pierre Fabre develop a 100% recycled PET packaging for ELUDRIL® brand mouthwashes
Bormioli Pharma and Pierre Fabre, a French pharmaceutical and dermo-cosmetic group present in more than 100 countries, are consolidating their partnership started in 2020 through an innovative initiative in eco-design and sustainable development.
Bormioli Pharma presents groundbreaking scientific data that show the undeniable safety of sustainable plastic packaging for medicines
Bormioli Pharma has presented a set of data highlighting that pharma-grade, sustainable plastic packaging is able to fulfill the strictest requirements of the industry in terms of quality and safety.
Bormioli Pharma issues its first ESG Report. Among the main objectives: -30% water consumption and CO2 emissions by 2030, 50% use of sustainable raw materials in production
Bormioli Pharma has published its first Sustainability Report according to ESG criteria, a document that reports on the Group's activities in terms of social responsibility during 2021 and that sets medium and long-term improvement objectives in line with its mission: "Making health a positive practice, accessible to all and kind to the planet".
Bormioli Pharma launches at Pharmapack Europe “EcoPositive”, a new range of planet-friendly packaging solutions
Bormioli Pharma announces the launch of EcoPositive, a brand new label gathering all the sustainable packaging solutions manufactured by the company.